For: | Tanaka T, Sakai A, Tsujimae M, Yamada Y, Kobayashi T, Masuda A, Kodama Y. Delayed immune-related sclerosing cholangitis after discontinuation of pembrolizumab: A case report. World J Gastroenterol 2022; 28(28): 3732-3738 [PMID: 36161046 DOI: 10.3748/wjg.v28.i28.3732] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i28/3732.htm |
Number | Citing Articles |
1 |
Seiya Ichihara, Michihiro Kunishige, Naoki Kadota, Yoshio Okano, Hisanori Machida, Nobuo Hatakeyama, Keishi Naruse, Tsutomu Shinohara, Eiji Takeuchi. Late‐onset acute type 1 diabetes mellitus 7 months after discontinuation of pembrolizumab against lung cancer. Thoracic Cancer 2023; 14(1): 81 doi: 10.1111/1759-7714.14736
|
2 |
Antineoplastics/methyprednisolone. Reactions Weekly 2022; 1929(1): 92 doi: 10.1007/s40278-022-25716-5
|